News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
657,980 Results
Type
Article (50204)
Company Profile (225)
Press Release (607522)
Multimedia
Podcasts (195)
Webinars (29)
Section
Business (178205)
Career Advice (2618)
Deals (32883)
Drug Delivery (165)
Drug Development (79731)
Employer Resources (173)
FDA (16764)
Job Trends (13799)
News (316220)
Policy (32817)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2467)
Academic (1)
Accelerated approval (49)
Adcomms (39)
Allergies (169)
Alliances (45042)
ALS (212)
Alzheimer's disease (1869)
Antibody-drug conjugate (ADC) (476)
Approvals (17034)
Artificial intelligence (689)
Autoimmune disease (298)
Automation (44)
Bankruptcy (331)
Best Places to Work (10192)
BIOSECURE Act (23)
Biosimilars (235)
Biotechnology (115)
Bladder cancer (188)
Brain cancer (70)
Breast cancer (728)
Cancer (5722)
Cardiovascular disease (486)
Career advice (2215)
Career pathing (48)
CAR-T (315)
CDC (75)
Celiac Disease (2)
Cell therapy (901)
Cervical cancer (46)
Clinical research (69281)
Collaboration (2002)
Company closure (8)
Compensation (1409)
Complete response letters (101)
COVID-19 (2823)
CRISPR (106)
C-suite (1105)
Cystic fibrosis (153)
Data (7638)
Decentralized trials (3)
Denatured (54)
Depression (181)
Dermatology (82)
Diabetes (584)
Diagnostics (6146)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (43)
Drug discovery (326)
Drug pricing (241)
Drug shortages (38)
Duchenne muscular dystrophy (296)
Earnings (75878)
Editorial (77)
Employer branding (20)
Employer resources (152)
Events (102239)
Executive appointments (1064)
FDA (20497)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (31)
Funding (1599)
Gene editing (234)
Generative AI (62)
Gene therapy (747)
GLP-1 (1210)
Government (4442)
Grass and pollen (8)
Guidances (400)
Healthcare (16216)
HIV (84)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (334)
Immuno-oncology (95)
Indications (186)
Infectious disease (3165)
Inflammatory bowel disease (228)
Inflation Reduction Act (15)
Influenza (134)
Intellectual property (282)
Interviews (483)
IPO (15535)
IRA (59)
Job creations (3882)
Job search strategy (1817)
JPM (73)
Kidney cancer (21)
Labor market (101)
Layoffs (647)
Leadership (50)
Legal (7943)
Liver cancer (102)
Longevity (28)
Lung cancer (749)
Lymphoma (420)
Machine learning (55)
Management (59)
Manufacturing (1036)
MASH (200)
Medical device (12090)
Medtech (12191)
Mergers & acquisitions (18544)
Metabolic disorders (1620)
mRNA (233)
Multiple sclerosis (193)
NASH (24)
Neurodegenerative disease (434)
Neuropsychiatric disorders (122)
Neuroscience (3435)
Neurotech (2)
NextGen: Class of 2026 (5544)
Non-profit (3475)
Now hiring (67)
Obesity (803)
Opinion (350)
Ovarian cancer (204)
Pain (253)
Pancreatic cancer (294)
Parkinson's disease (373)
Partnered (29)
Patents (593)
Patient recruitment (667)
Peanut (62)
People (54760)
Pharmaceutical (85)
Pharmacy benefit managers (36)
Phase 1 (21383)
Phase 2 (30115)
Phase 3 (23407)
Pipeline (8413)
Policy (380)
Postmarket research (2616)
Preclinical (8750)
Press Release (50)
Prostate cancer (301)
Psychedelics (67)
Radiopharmaceuticals (319)
Rare diseases (1154)
Real estate (5467)
Recruiting (70)
Regulatory (26012)
Reports (51)
Research institute (2316)
Resumes & cover letters (430)
Rett syndrome (39)
RNA editing (24)
RSV (89)
Schizophrenia (188)
Series A (279)
Series B (206)
Service/supplier (14)
Sickle cell disease (118)
Special edition (31)
Spinal muscular atrophy (176)
Sponsored (52)
Startups (3406)
State (2)
Stomach cancer (21)
Supply chain (133)
Tariffs (104)
The Weekly (138)
Vaccines (1202)
Venture capital (117)
Weight loss (564)
Women's health (112)
Worklife (24)
Date
Today (182)
Last 7 days (911)
Last 30 days (3483)
Last 365 days (30200)
2026 (11986)
2025 (30192)
2024 (33888)
2023 (37953)
2022 (48577)
2021 (52355)
2020 (49727)
2019 (40558)
2018 (30956)
2017 (31272)
2016 (30063)
2015 (33728)
2014 (27400)
2013 (23041)
2012 (24703)
2011 (25297)
2010 (23250)
Location
Africa (806)
Alabama (79)
Alaska (7)
Arizona (291)
Arkansas (14)
Asia (40820)
Australia (6587)
California (12723)
Canada (3317)
China (1327)
Colorado (535)
Connecticut (580)
Delaware (400)
Europe (92995)
Florida (1924)
Georgia (388)
Hawaii (4)
Idaho (48)
Illinois (977)
India (87)
Indiana (534)
Iowa (23)
Japan (536)
Kansas (117)
Kentucky (47)
Louisiana (35)
Maine (79)
Maryland (1552)
Massachusetts (9267)
Michigan (303)
Minnesota (668)
Mississippi (5)
Missouri (133)
Montana (21)
Nebraska (26)
Nevada (132)
New Hampshire (70)
New Jersey (3429)
New Mexico (28)
New York (3310)
North Carolina (1672)
North Dakota (8)
Northern California (6418)
Ohio (359)
Oklahoma (19)
Oregon (38)
Pennsylvania (2474)
Puerto Rico (27)
Rhode Island (40)
South America (1177)
South Carolina (82)
South Dakota (2)
Southern California (5013)
Tennessee (189)
Texas (1949)
United States (44762)
Utah (320)
Virginia (321)
Washington D.C. (81)
Washington State (1009)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
657,980 Results for "galderma pharma s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
Lilly, J&J CEOs top pharma’s highest paid list—again
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by more than $4 million.
May 13, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
Galderma’s Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years
February 27, 2026
·
8 min read
Press Releases
Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing
March 23, 2026
·
11 min read
Press Releases
Galderma Shareholders Approve All Annual General Meeting Proposals
April 23, 2026
·
2 min read
Press Releases
TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics
January 15, 2026
·
6 min read
Press Releases
Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission
February 2, 2026
·
5 min read
Press Releases
Galderma Announces Appointment of New Chief Financial Officer
February 16, 2026
·
4 min read
Podcast
Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
The approval of Eli Lilly’s oral obesity drug officially ignites an intense competition with Novo Nordisk’s oral Wegovy; Gilead Sciences and Neurocrine Biosciences keep the M&A train chugging; Trump hits pharma with his long promised tariffs, and the FDA proposes many changes with 2027 budget.
April 8, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Galderma Debuts ALASTIN Signature Practices in Partnership With Leading Aesthetic Practices to Elevate Regenerative, Peri-Procedural Skincare
April 7, 2026
·
4 min read
Press Releases
Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency
April 23, 2026
·
16 min read
1 of 65,798
Next
